The changing circumstance of atrial fibrillation - progress towards precision medicine

Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation

(2015) Julia Aulin et al.   AMERICAN HEART JOURNAL

Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China

(2015) Yutao Guo et al.   CHEST

Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study

(2015) E. Svennberg et al.   CIRCULATION

Galectin-3 in atrial fibrillation: Simple bystander, player or both?

(2015) Giuseppe Lippi et al.   CLINICAL BIOCHEMISTRY

Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease

(2015) Xiao-Yan Wu et al.   EUROPACE

The European Network for Translational Research in Atrial Fibrillation (EUTRAF): objectives and initial results

(2015) Ulrich Schotten et al.   EUROPACE

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

(2015) Giuseppe Boriani et al.   EUROPACE

Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording

(2015) Mattias Aronsson et al.   EUROPACE

Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults

(2015) Fima Macheret et al.   HEART

Stroke Risk Stratification in Patients With Atrial Fibrillation

(2015) A. John Camm et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality

(2015) Rob A. Vermond et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?

(2015) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation

(2015) Rajeev K. Pathak et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort

(2015) Rajeev K. Pathak et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015) Theo Vos et al.   LANCET

The future of atrial fibrillation therapy: intervention on heat shock proteins influencing electropathology is the next in line

(2015) E.A.H. Lanters et al.   Netherlands Heart Journal

Racial Differences in the Prevalence of Atrial Fibrillation among Males

(2015) Ann M. Borzecki et al.   JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION

Galectin-3 in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation

(2015) Jelena Kornej et al.   PLoS One

Metabolomics and Incidence of Atrial Fibrillation in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study

(2015) Alvaro Alonso et al.   PLoS One

Galectin 3 and incident atrial fibrillation in the community

(2014) Jennifer E. Ho et al.   AMERICAN HEART JOURNAL

Management and 1-Year Outcomes of Patients With Atrial Fibrillation in the Middle East

(2014) Mohammad Zubaid et al.   ANGIOLOGY

Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort

(2014) Eduard Shantsila et al.   BRITISH JOURNAL OF GENERAL PRACTICE

Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries

(2014) Jonas Oldgren et al.   CIRCULATION

Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation

(2014) Lars Wallentin et al.   CIRCULATION

Fibroblast Growth Factor-23 and Incident Atrial Fibrillation

(2014) Jehu S. Mathew et al.   CIRCULATION

Comparison of Cardiac Troponins I and T Measured with High-Sensitivity Methods for Evaluation of Prognosis in Atrial Fibrillation: An ARISTOTLE Substudy

(2014) Z. Hijazi et al.   CLINICAL CHEMISTRY

Work-up and management of lone atrial fibrillation: results of the European Heart Rhythm Association Survey

(2014) L. Pison et al.   EUROPACE

B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies

(2014) Moritz F. Sinner et al.   EUROPACE

Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies

(2014) L. Li et al.   EUROPACE

Early management of atrial fibrillation to prevent cardiovascular complications

(2014) S. Nattel et al.   EUROPEAN HEART JOURNAL

Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials

(2014) Ruairidh I R Martin et al.   HEART

Lone Atrial Fibrillation

(2014) D. George Wyse et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cryptogenic Stroke and Underlying Atrial Fibrillation

(2014) Tommaso Sanna et al.   NEW ENGLAND JOURNAL OF MEDICINE

Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. A Danish cohort study

(2014) Lars Frost et al.   Obesity

Relationship between Brain Natriuretic Peptides and Recurrence of Atrial Fibrillation after Successful Direct Current Cardioversion: A Meta-Analysis

(2014) THEODOROS ZOGRAFOS et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Multiple Biomarkers and Atrial Fibrillation in the General Population

(2014) Renate B. Schnabel et al.   PLoS One

Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies

(2014) Nicole Lowres et al.   THROMBOSIS AND HAEMOSTASIS

Value of high-sensitivity C-reactive protein assays in predicting atrial fibrillation recurrence: a systematic review and meta-analysis

(2014) Chia-Hung Yo et al.   BMJ Open

Circulating Fibroblast Growth Factor‐23 and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study

(2014) Alvaro Alonso et al.   Journal of the American Heart Association

Incident Atrial Fibrillation Among Asians, Hispanics, Blacks, and Whites

(2013) Thomas A. Dewland et al.   CIRCULATION

“R” for “Renal” and for “Risk”

(2013) A. John Camm et al.   CIRCULATION

High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation

(2013) Ziad Hijazi et al.   CIRCULATION

Worldwide Epidemiology of Atrial Fibrillation

(2013) Sumeet S. Chugh et al.   CIRCULATION

Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation

(2013) Ziad Hijazi et al.   CIRCULATION

Association Between C-Reactive Protein and Atrial Fibrillation Recurrence After Catheter Ablation: A Meta-analysis

(2013) Zhouqin Jiang et al.   CLINICAL CARDIOLOGY

Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study

(2013) Deniz Karasoy et al.   EUROPACE

Lone atrial fibrillation as a positive predictor of left atrial volume reduction following ablation of atrial fibrillation

(2013) S. Fredersdorf et al.   EUROPACE

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

(2013) P. Kirchhof et al.   EUROPACE

Biomarkers in atrial fibrillation: a clinical review

(2013) Z. Hijazi et al.   EUROPEAN HEART JOURNAL

Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060

(2013) B. P. Krijthe et al.   EUROPEAN HEART JOURNAL

Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a ‘real-world’ community cohort of patients with atrial fibrillation

(2013) Suresh Krishnamoorthy et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation

(2013) Hany S. Abed et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation

(2013) Ziad Hijazi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Novel Association between Plasma Matrix Metalloproteinase-9 and Risk of Incident Atrial Fibrillation in a Case-Cohort Study: The Atherosclerosis Risk in Communities Study

(2013) Rachel R. Huxley et al.   PLoS One

Increased risk of atrial fibrillation among elderly Norwegian men with a history of long-term endurance sport practice

(2013) M. Myrstad et al.   SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS

A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk Score

(2013) Daniel E. Singer et al.   Journal of the American Heart Association

A proposal for new clinical concepts in the management of atrial fibrillation

(2012) A. John Camm et al.   AMERICAN HEART JOURNAL

Brain Natriuretic Peptide Levels as a Predictor for New Atrial Fibrillation During Hospitalization in Patients With Acute Ischemic Stroke

(2012) Kensaku Shibazaki et al.   AMERICAN JOURNAL OF CARDIOLOGY

The Global Burden of Atrial Fibrillation and Stroke

(2012) Gregory Y.H. Lip et al.   CHEST

Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation

(2012) Ziad Hijazi et al.   CIRCULATION

Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation

(2012) Jonathan P. Piccini et al.   CIRCULATION

Proteomics of Atrial Fibrillation

(2012) Ayesha I. De Souza et al.   Circulation-Arrhythmia and Electrophysiology

Prognostic value of left atrial expansion index and exercise-induced change in atrial natriuretic peptide as long-term predictors of atrial fibrillation recurrence

(2012) Malini Govindan et al.   EUROPACE

Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)

(2012) Leif Friberg et al.   EUROPACE

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

(2012) Stefan H. Hohnloser et al.   EUROPEAN HEART JOURNAL

Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls

(2012) Bob Weijs et al.   HEART RHYTHM

The prevalence of atrial fibrillation in a geographically well-defined population in Northern Sweden: implications for anticoagulation prophylaxis

(2012) P. Andersson et al.   JOURNAL OF INTERNAL MEDICINE

Electrophysiological and Hemodynamic Characteristics Associated With Obesity in Patients With Atrial Fibrillation

(2012) Thomas M. Munger et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

(2012) Jonas Bjerring Olesen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Subclinical Atrial Fibrillation and the Risk of Stroke

(2012) Jeff S. Healey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fibrin D-Dimer, Tissue-Type Plasminogen Activator, von Willebrand Factor, and Risk of Incident Stroke in Older Men

(2012) S. Goya Wannamethee et al.   STROKE

Atrial Fibrillation and the Risk of Sudden Cardiac Death

(2012) Lin Y. Chen et al.   JAMA Internal Medicine

Atrial Remodeling, Autonomic Tone, and Lifetime Training Hours in Nonelite Athletes

(2011) Matthias Wilhelm et al.   AMERICAN JOURNAL OF CARDIOLOGY

A 12-Year Follow-up Study of Patients With Newly Diagnosed Lone Atrial Fibrillation

(2011) Tatjana S. Potpara et al.   CHEST

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

(2011) P. Kirchhof et al.   EUROPACE

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

(2011) I. Savelieva et al.   EUROPACE

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

(2011) I. Savelieva et al.   EUROPACE

Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections

(2011) Hrafnhildur Stefansdottir et al.   EUROPACE

The burden of atrial fibrillation in the Netherlands

(2011) H. E. Heemstra et al.   Netherlands Heart Journal

Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study

(2010) Alanna M. Chamberlain et al.   AMERICAN HEART JOURNAL

Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the Community

(2010) Renate B. Schnabel et al.   CIRCULATION

Pericardial Fat Is Associated With Prevalent Atrial Fibrillation

(2010) George Thanassoulis et al.   Circulation-Arrhythmia and Electrophysiology

A Study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation

(2010) R. Fu et al.   EUROPACE

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE

High prevalence of atrial fibrillation in long-term endurance cross-country skiers: echocardiographic findings and possible predictors — a 28-30 years follow-up study

(2010) Jostein Grimsmo et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-Atrial Fibrillation Trial

(2010) R. Latini et al.   JOURNAL OF INTERNAL MEDICINE

Evidence That D-Dimer Levels Predict Subsequent Thromboembolic and Cardiovascular Events in Patients With Atrial Fibrillation During Oral Anticoagulant Therapy

(2010) Tsuneaki Sadanaga et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Long- and Short-Term Impact of Elevated Body Mass Index on the Risk of New Atrial Fibrillation

(2010) Usha B. Tedrow et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation

(2009) Kristen K. Patton et al.   CIRCULATION

Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation

(2009) Alan S. Go et al.   CIRCULATION

The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk

(2009) Taya V. Glotzer et al.   Circulation-Arrhythmia and Electrophysiology

Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis

(2009) J. Abdulla et al.   EUROPACE

Atrial fibrillation in fracture patients treated with oral bisphosphonates

(2009) B. Abrahamsen et al.   JOURNAL OF INTERNAL MEDICINE

Physical Activity and Incidence of Atrial Fibrillation in Older Adults

(2008) Dariush Mozaffarian et al.   CIRCULATION

Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter

(2008) L. Mont et al.   EUROPACE

Interleukin-6 and atrial fibrillation in patients with coronary artery disease: Data from the Heart and Soul Study

(2007) Gregory M. Marcus et al.   AMERICAN HEART JOURNAL

Status of the Epidemiology of Atrial Fibrillation

(2007) William B. Kannel et al.   MEDICAL CLINICS OF NORTH AMERICA